SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 

 
FORM 8-K
 
CURRENT REPORT
Pursuant To Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  June 1, 2010
 
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
(Exact Name of Registrant
as Specified in Charter)
 
 
Delaware
  
 
(State or Other Jurisdiction of Incorporation)
  
 
001-15943
  
06-1397316
(Commission File Number)
  
(IRS Employer Identification No.)
 
251 Ballardvale Street
Wilmington, Massachusetts
  
01887
(Address of Principal Executive Offices)
  
(Zip Code)
 
     
Registrant’s telephone number, including area code:  (978) 658-6000
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
  o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
  o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
  o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
Item 9.01. Financial Statements and Exhibits
 
 
Exhibit No.
  
Description
 
23.1
  
Consent of Deloitte Touche Tohmatsu CPA Ltd.


 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
Charles River Laboratories, Inc.
  
       
       
Date:
June 1, 2010
  
By:
/s/ Matthew Daniel
  
       
Name:
 Matthew Daniel
  
       
Title:
 Deputy General Counsel and
Assistant Secretary
  

 
 
 

INDEX TO EXHIBITS

 
Exhibit No.
  
Description
 
23.1
  
Consent of Deloitte Touche Tohmatsu CPA Ltd.